CRIS Current Research Information System

BUONTEMPO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.335
EU - Europa 1.597
AS - Asia 927
AF - Africa 101
SA - Sud America 9
OC - Oceania 3
Totale 4.972
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.328
GB - Regno Unito 415
CN - Cina 324
IT - Italia 280
SE - Svezia 273
VN - Vietnam 271
DE - Germania 217
SG - Singapore 188
RU - Federazione Russa 92
IN - India 75
IE - Irlanda 70
FR - Francia 58
UA - Ucraina 45
TG - Togo 41
ZA - Sudafrica 40
EE - Estonia 34
JO - Giordania 30
CH - Svizzera 25
IR - Iran 20
BG - Bulgaria 18
BE - Belgio 16
AT - Austria 14
FI - Finlandia 12
CI - Costa d'Avorio 9
CL - Cile 9
CA - Canada 7
NG - Nigeria 6
NL - Olanda 5
PT - Portogallo 5
RO - Romania 5
LB - Libano 4
ES - Italia 3
ID - Indonesia 3
JP - Giappone 3
PL - Polonia 3
AU - Australia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GR - Grecia 2
KR - Corea 2
TR - Turchia 2
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
LK - Sri Lanka 1
MA - Marocco 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 4.972
Salva come PNG Salva come JPEG
Città #
Southend 375
Fairfield 267
Chandler 196
Ashburn 194
Dong Ket 173
Houston 166
Singapore 152
Woodbridge 150
Wilmington 138
Bologna 131
Seattle 126
Santa Clara 118
Ann Arbor 105
Cambridge 88
Princeton 83
Dublin 70
Boardman 55
Lomé 41
New York 41
Nanjing 40
Westminster 40
Padova 35
Amman 30
Berlin 25
Bern 24
Bremen 24
Beijing 22
Jinan 21
Shenyang 21
Jacksonville 19
Changsha 18
Saint Petersburg 18
Sofia 18
Brussels 15
Turin 14
Falls Church 13
Nanchang 13
Florence 12
Helsinki 12
Frankfurt am Main 11
Vienna 11
Guangzhou 10
Haikou 10
Hangzhou 10
Medford 10
Norwalk 10
Redmond 10
San Diego 10
Zhengzhou 10
Abidjan 9
Hebei 9
Rome 8
Tianjin 8
Dearborn 7
Mülheim 7
Pune 7
Shanghai 7
Abeokuta 6
Falkenstein 6
Fuzhou 6
Jiaxing 6
Ningbo 6
Nuremberg 6
Toronto 6
London 5
Los Angeles 5
Redwood City 5
Washington 5
Yubileyny 5
Andover 4
Clearwater 4
Kuban 4
Olalla 4
Plauen 4
Zanjan 4
Bühl 3
Castiglione Delle Stiviere 3
Chieri 3
Hefei 3
Jakarta 3
Kashan 3
Kish 3
Kunming 3
Milan 3
Mountain View 3
Phoenix 3
San Francisco 3
Taiyuan 3
Trapani 3
Trento 3
Amsterdam 2
Borgoricco 2
Bucharest 2
Casalecchio di Reno 2
Cedar Knolls 2
Chengdu 2
Chicago 2
Den Haag 2
Dongguan 2
Düsseldorf 2
Totale 3.423
Salva come PNG Salva come JPEG
Nome #
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 203
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 192
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 187
Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device 182
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a 158
Early biological effects of ultra-high compare to standard dose rate of X-rays on a radioresistant cell line 158
Dosimetric analysis and experimental setup design for in-vivo irradiation with a Plasma Focus device 158
Therapeutic targeting of CK2 in acute and chronic leukemias. 155
Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells. 148
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. 147
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 141
Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. 136
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 134
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 133
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 130
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 128
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 127
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 125
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 124
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 123
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 122
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 122
Nuclear phosphoinositides and their roles in cell biology and disease. 116
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 109
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 108
GSK-3β: a key regulator of breast cancer drug resistance 105
Drug discovery targeting the mTOR pathway 103
Protective effect of different antioxidant agents in UVB-irradiated keratinocytes 99
Diet modulation restores autophagic flux in damaged skeletal muscle cells. 99
null 95
Marine bisindole alkaloid: a potential apoptotic inducer in cancer cells. 92
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 90
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. 84
Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status 83
null 75
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 75
Dose-current discharge correlation analysis in a Mather type Plasma Focus device for medical applications 70
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells 70
null 61
null 52
Compact and very high dose-rate plasma focus radiation sources for medical applications 46
null 45
null 43
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 42
EVALUATION OF THE EFFICACY AND ANTITUMOR ACTIVITY OF THE PAN-CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITOR NVP-BKM120 IN HUMAN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) 35
HNE protein adducts and apoptosis in osteosarcoma cells 30
INHIBITION OF CLASS I PHOSPHATIDYLINOSITOL 3-KINASES (PI3KS) ISOFORMS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): WHICH IS THE BEST THERAPEUTIC STRATEGY? 26
Tyrosol prevents apoptosis in irradiated keratinocytes. 23
Totale 5.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.185
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020384 0 0 0 0 0 0 0 0 184 71 51 78
2020/2021642 118 47 15 19 7 15 15 27 58 24 31 266
2021/2022947 148 19 61 59 78 48 19 61 33 126 180 115
2022/2023945 85 130 52 146 59 69 33 48 180 10 80 53
2023/2024295 21 40 26 33 27 95 5 10 7 12 8 11
2024/2025626 16 121 87 69 192 48 63 30 0 0 0 0
Totale 5.109